Lisocabtagene Maraleucel in Relapsed or Refractory Diffuse Large B Cell Lymphoma: What is the Evidence?

Lisocabtagene maraleucel (liso-cel) is an autologous CD19-directed chimeric antigen receptor (CAR) T cell product, with a CD3Z activatory domain connected to 4-1BB costimulatory domain. Liso-cel, unlike the other two approved products—axicabtagene ciloleucel and tisagenlecleucel—is manufactured sepa...

Descrición completa

Detalles Bibliográficos

Principais autores:	Mohamed A. Kharfan-Dabaja, Farah Yassine, Muhamad Alhaj Moustafa, Madiha Iqbal, Hemant Murthy
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wolters Kluwer Medknow Publications 2022-10-01
Series:	Hematology/Oncology and Stem Cell Therapy
Assuntos:	cd19 chimeric antigen receptor t cell diffuse large b cell non-hodgkin lymphoma lisocabtagene maraleucel
Acceso en liña:	https://journals.lww.com/10.1016/j.hemonc.2021.09.004
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!